文献速递母胎医学

比利时产前微阵列(BEMAPRE)数据库:全国性胎儿基因组变异系统化登记库

The Belgian MicroArray Prenatal (BEMAPRE) database: A systematic nationwide repository of fetal genomic aberrations.
PubMed 文献 · Prenat Diagn · 2018-11-14

比利时所有遗传中心联合建立全国产前染色体微阵列(CMA)数据库,收集2013年5月至2016年7月全部侵入性产前操作数据,共完成13 266例产前CMA;全国统一报告政策下,CMA较传统核型的附加值为一般侵入性人群1.8%、超声异常者2.7%,31.5%的报告变异以无创产前检测为首选将不被发现。

要点

  • 比利时全国遗传中心协作建立产前CMA数据库,统一拷贝数变异(CNV)分类与报告。
  • 3年共完成13 266例产前CMA,按全国共识仅报告有限易感性CNV,不报告意义不明变异。
  • CMA较传统核型附加值:一般侵入性人群1.8%,超声异常者2.7%;31.5%报告CNV以NIPT为首选将漏检。

核心结论

  • 建立全国产前CNV数据库可实现统一报告政策,并有助于研究产前与产后基因型-表型关联。

研究设计与样本

  • 比利时所有遗传中心组成的BEMAPRE联盟,收集2013年5月至2016年7月全部侵入性产前操作数据,共13 266例产前CMA。

主要发现

  • 3年期间共完成13 266例产前CMA。
  • CMA较传统核型的附加值在一般侵入性人群为1.8%,在超声异常病例为2.7%。
  • 报告的CNV中31.5%若以无创产前检测(NIPT)为首选将不会被发现。

关键数值与推荐

  • 按全国协议,仅报告有限数量的易感性CNV,不报告意义不明变异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal diagnosis, new challenges have arisen. By building a national database, we standardize the classification and reporting of prenatally detected copy number variants (CNVs) across Belgian genetic centers. This database, which will link genetic and ultrasound findings with postnatal development, forms a unique resource to investigate the pathogenicity of variants of uncertain significance and to refine the phenotypic spectrum of pathogenic and susceptibility CNVs. METHODS: The Belgian MicroArray Prenatal (BEMAPRE) consortium is a collaboration of all genetic centers in Belgium. We collected data from all invasive prenatal procedures performed between May 2013 and July 2016. RESULTS: In this three-year period, 13 266 prenatal CMAs were performed. By national agreement, a limited number of susceptibility CNVs and no variants of uncertain significance were reported. Added values for using CMA versus conventional karyotyping were 1.8% in the general invasive population and 2.7% in cases with an ultrasound anomaly. Of the reported CNVs, 31.5% would have remained undetected with non-invasive prenatal test as the first-tier test. CONCLUSION: The establishment of a national database for prenatal CNV data allows for a uniform reporting policy and the investigation of the prenatal and postnatal genotype-phenotype correlation.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Muys J, Blaumeiser B, Jacquemyn Y, et al. The Belgian MicroArray Prenatal (BEMAPRE) database: A systematic nationwide repository of fetal genomic aberrations. Prenat Diagn. 2018. PMID: 30334587. doi:10.1002/pd.5373

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。